Earth Science Tech (OTC: ETST), an innovative biotech company focused on the cannabidiol (“CBD”), nutraceutical and pharmaceutical fields as well as medical devices and research and development, is poised to gain its share of the ever-growing cannabis sector. An article discussing the company reads: “To enter this brave new world of cannabis liberalization, ETST is developing a portfolio of new products while aggressively pursuing growth through joint ventures and acquisitions. In this vein, newly created division Cannabis Therapeutic Inc. will develop proprietary cannabinoid-based nutraceuticals and pharmaceutical products based on an existing CBD patent. The company continues its activities in the hemp-derived cannabinoid (CBD), nutraceutical, pharmaceutical and medical device markets. In addition, it is pursuing a vigorous program of R&D and continued development of its marketing and distribution channels.”
To view the full article, visit http://ibn.fm/sa2oD
About Earth Science Tech, Inc.
Earth Science Tech, Inc. (“ETST”) offers the highest purity and quality, high-grade full spectrum cannabinoid oil on the market. Thanks to its positive result studies on breast cancer and immune cells through the University of Central Oklahoma, studies through DV Biologics proving to lower cortisol and as a neuroprotectant, positive result case studies through key health organizations. ETST formulates, markets, and distributes the CBD oil used for its studies to the public, offering the most effective quality of CBD in the market. For more information, visit the company’s website at www.EarthScienceTech.com.
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
